Navigation Links
Medivation Announces Upcoming Scientific Presentations at Medical Conferences
Date:4/23/2009

in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause Medivation's actual results to differ significantly from those projected, including, without limitation, risks related to progress, timing and results of Medivation's clinical trials, difficulties or delays in obtaining regulatory approval, enrollment of patients in Medivation's clinical trials, partnering of Medivation's product candidates, manufacturing of Medivation's product candidates, competition with Medivation's product candidates should they receive marketing approval, the adequacy of Medivation's financial resources, unanticipated expenditures or liabilities, intellectual property matters, and other risks detailed in Medivation's filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2008, filed with the SEC on March 16, 2009. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Medivation disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
2. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Senior Management Promotions
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
7. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
8. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
9. Medivation Announces Participation in Upcoming Conferences
10. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
11. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
(Date:11/24/2009)...y,November24/PRNewswire/--HealthRoboticstodayannou...roupofselected,investors.ThisrecentlyformedToronto...sCanada,Inc.andwillmarket,install,andsupport,Healt...the,revolutionaryproductofferingsi.v.STATION(TM),i...llalsoprovideassistanceonan"asneeded,basis"toitsst...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--CellTherapeutics,Inc.(...1stAnnualPiperJaffrayHealthCareConference.Theconfe...Hotel. ,, CTIwillpresentonTuesday,December1at11...bcastofCTI,spresentationwillbeavailableat www.cell...yafterwards. , ,PiperJaffrayHealthCareConference,...
(Date:11/23/2009)...g promises ultra-fast communication, computation a...tion. But trying to use quantum states as carriers... Now two physicists have shown, mathematically, ho...mmunication, while keeping the information intact....hysical Review Letters and highlighted with a Vie...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...tions , a Midwestern company building cross-platfo...OS X, has announced a free trial of its link aggr...tation of the IEEE 802.3ad standard , combines mu...al interface, combining the individual ports, band...ilt-in redundancy. Small Tree remains the only com...
...erent types of patent searches you can use to help...etitors patents, (2) a clearance search, (3) a pat...5) a patent validity search. Each type of search h... A search for competitors patents ,A search for c...iodic basis and looks for patents that issue to on...
...formance of Midwest publicly traded biotech compan...erformance of the major U.S. stock indices. The Am...easure the biotech sector in different ways. , ,Th...h stocks (most of which are the large-cap biotech ... Midwest biotech companies are listed on this inde...
Other Biology Technology:Five ways your company can benefit from patent searches 2Five ways your company can benefit from patent searches 3VC Community Shares Perspectives on Midwest Life Science Funding 2VC Community Shares Perspectives on Midwest Life Science Funding 3VC Community Shares Perspectives on Midwest Life Science Funding 4
(Date:11/23/2009)...ty of New Hampshire microbiologist Louis Tisa has ...nderstanding of the actinorhizal plants, widesprea...oor and contaminated soils. , The United States...professor of molecular, cellular and biomedical sc...ship between the bacteria Frankia and Casuarina, a...
(Date:11/23/2009)...g of recent discoveries about the multiple health ... multi-purpose nutrient, increased awareness of th...spurred research and even led to an appreciation o...ng from the health of your immune system to preven...fluenza, vitamin D is now seen as one of the most ...
(Date:11/23/2009)...f General Medical Sciences (NIGMS), part of the Na...2.3 million for grants in scientific areas it iden...d the GO grant program to stimulate biomedical res...American Recovery and Reinvestment Act (Recovery A... to have a significant impact on a field of biomed...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 53942 1Hospice Partners On Call Selects Category 5 Hurricane Rated 1Vault Networks to Safeguard Server and Call Center Infrastructure 53942 2Expanding Health Coverage May Not Improve Access 53940 1Expanding Health Coverage May Not Improve Access 53940 2Expanding Health Coverage May Not Improve Access 53940 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 1Electronic Health Records Help Cardiac Patients Remain Healthy 53938 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 4
...ant to understand extreme sea creaturesExtraordina...ions are being investigated by University scientis...ties could reveal an evolutionary history differen... to how life could exist onother planets. , The c...ly hot environments in the deep sea - and are uniq...
... have developed a rapid, less costly and sensitive..., the bacteria that cause scarlet fever. Details w...chnologists Annual Meeting and Food Expo in New Or... student in Cornell,s food science department, wil...tococcus pyogenes (S. pyogenes ), but the techniqu...
...nse selective logging stopped in the region now kn...ed guenon (Cercophithecus ascanius) is a primate s...report in a new study, changed the ecological bala...es and opening the door for multiple parasitic inf...e species, collecting 1,076 fecal samples from the...
Other Biology News:New technique rapidly detects illness-causing bacteria 2New technique rapidly detects illness-causing bacteria 3Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 2Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping 3
MutaGEL Parodontitis from Alpco Diagnostics
Polystyrene Plate Cover with stacking ridge from ABgene
...dular, computer controlled pre-amplifier suitable ...lated electrode input for recording physiological ...ucer input for use with a wide range of bridge and...timulus artefact clamp to avoid saturation when us...
SYBR Green Nucleic Acid Dye from MBL International
Biology Products: